CHAIN aims to build value for our stakeholders while delivering positive societal impacts in a sustainable, ethical and principled manner. We do this by demonstrating technology excellence and leadership, and by working closely with partners to build trust and confidence.
CHAIN seeks academic partners that can support target discovery. We have a track record obtaining UK and EU grant awards to support collaborative research projects.
CHAIN also seeks strategic development partners from microbiome and biotech companies that can provide novel discovery targets for inclusion into our strain development programme and delivery platform.
CHAIN seeks licensing partners from the healthcare and pharmaceutical industries for our lead asset CHN-1 which delivers a potent anti-inflammatory molecule to the gut targeting inflammatory bowel disease.
Building a team of experts:
At CHAIN, we are building a team of expert scientists and business specialists to develop the company into a global healthcare leader specialising in diseases related to the human microbiome. We value hard work and creativity, and seek talented individuals who share our founder’s vision.
Besides any specific current opportunities listed below, we are keen to hear from exceptional candidates across a number of focus areas: the human microbiome, immunology, synthetic biology, and regulatory affairs. Expertise within a clinical setting, working with anaerobes, and taking therapeutics to market is desirable. In addition we are interested in experts who can help shape and manage the drug development process in our business operations.
CHAIN is committed to promoting equal opportunities in employment. The company offers a competitive compensation and benefits package. If you are interested in working for CHAIN please contact email@example.com
There are no opportunities at this time.